Gin Hwa Biotech (ROCO:7806) GF Score: 22/100 (As of Jul. 22, 2026) — 10% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:7806 Gin Hwa Biotech Inc ROCO:7806
22 GF Score
Price NT$61.90
! 2 Warning Signs
View Full Analysis

What is Gin Hwa Biotech GF Score?

Gin Hwa Biotech ROCO:7806 22 GF Score is 22 as of Jul. 22, 2026, which is 10% above its 10-year median of 20.00. GuruFocus rates ROCO:7806 with a GF Score™ of 22/100. The stock has 2 warning signs investors should review.

Gin Hwa Biotech has the GF Score of 22, which implies that the company might have Worst future performance potential, or not enough data.

The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.

GF Score takes following five key aspects into consideration:

1. Financial Strength : 6/10
2. Profitability Rank : 5/10
3. Growth Rank : 0/10
4. GF Value Rank : 0/10
5. Momentum Rank : 0/10

Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.

Based on research and backtesting result, GuruFocus believes Gin Hwa Biotech might have Worst future performance potential, or not enough data.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

Gin Hwa Biotech  (ROCO:7806) GF Score Explanation

Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:

GF Score Performance Potential and All-in-One Screener Examples (1)
91 - 100Highest outperformance potential
81 - 90Good outperformance potential
71 - 80Likely to have average performance
51 - 70Poor future performance potential
0 - 50Worst future performance potential, or not enough data

(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.

Gin Hwa Biotech GF Score Related Terms

ROCO:7806 vs VRTX, REGN, ALNY: GF Score Comparison

For the Biotechnology subindustry, Gin Hwa Biotech's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Gin Hwa Biotech GF Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Gin Hwa Biotech's GF Score distribution charts can be found below:

* The bar in red indicates where Gin Hwa Biotech's GF Score falls into.


ROCO:7806
22GF Score
Gin Hwa Biotech Inc ROCO:7806
GF Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about GF Score →
What does a GF Score of 22 mean?
Gin Hwa Biotech (ROCO:7806) has a GF Score of 22 as of Jul. 22, 2026. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Gin Hwa Biotech and its competitors. This is 10% above median its historical median of 20.00. Over the past decade, Gin Hwa Biotech's GF Score has ranged from 15.00 to 25.00.
Is Gin Hwa Biotech's GF Score too high?
Gin Hwa Biotech's current GF Score of 22 is 10% above median its 10-year median of 20.00. Over the past 10 years, this metric has ranged from a low of 15.00 to a high of 25.00. Overall, Gin Hwa Biotech has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Gin Hwa Biotech's GF Score compare to VRTX and REGN?
Gin Hwa Biotech's GF Score of 22 can be compared against companies in the Biotechnology industry. Historically, Gin Hwa Biotech's own GF Score has ranged from 15.00 to 25.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Score for a Biotechnology company?
A good GF Score depends on the Biotechnology industry context. However, GF Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Score mean?
A high GF Score can signal that a stock is expensive relative to its fundamentals. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Gin Hwa Biotech and its competitors. Gin Hwa Biotech's current GF Score is 22, which is 10% above median its own 10-year median of 20.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gin Hwa Biotech stock overvalued right now?
Gin Hwa Biotech (ROCO:7806) has a current GF Score of 22. The current GF Score is 22, which is 10% above median its 10-year median of 20.00. Gin Hwa Biotech's overall GF Score™ is 22/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Score calculated?
GF Score is calculated from a company's financial statements. For Gin Hwa Biotech (ROCO:7806), the current GF Score is 22 as of Jul. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Gin Hwa Biotech Business Description

Address No. 5, Guangming 7th Lane, Weixin Road, 1st Floor, Yong'an District, Kaohsiung, TWN, 828
Gin Hwa Biotech Inc is engaged in developing completely original products to achieve every vision. Its Services and technology are Product Development, OEM Service, Core Technology, R & D Center, Professional Production, and Others.
22GF Score

Get the complete analysis for ROCO:7806

GF Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$61.90
Price